Pavel E. Olivera

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Refractoriness to eltrombopag in adult primary immune thrombocytopenia: utility of next-generation sequencing techniques.

Refractoriness to eltrombopag in adult primary immune thrombocytopenia: utility of next-generation sequencing techniques.

Journal: Blood vessels, thrombosis & hemostasis

Published: May 20, 2024

Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients.

Interplay of leucocyte-platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients.

Journal: British journal of haematology

Published: May 16, 2024

Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the "ACO-VID" Registry.

Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the "ACO-VID" Registry.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: October 30, 2023

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation.

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: June 07, 2023

Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry.

Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry.

Journal: Current medical research and opinion

Published: May 16, 2023

Portal vein thrombosis in a patient with severe hemophilia B: A challenging balanced management.

Portal vein thrombosis in a patient with severe hemophilia B: A challenging balanced management.

Journal: Clinical case reports

Published: May 04, 2023

Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19.

Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19.

Journal: Seminars in thrombosis and hemostasis

Published: October 21, 2020

Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia.

Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia.

Journal: European journal of haematology

Published: October 08, 2019

Tromboc@t Working Group recommendations for management in patients receiving direct oral anticoagulants.

Tromboc@t Working Group recommendations for management in patients receiving direct oral anticoagulants.

Journal: Medicina clinica

Published: August 07, 2017

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.

Journal: International journal of hematology

Published: January 18, 2017

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.

Journal: British journal of haematology

Published: January 02, 2017

Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice.

Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice.

Journal: European journal of haematology

Published: December 17, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026